Cancer drug price spikes 1,400% with no generic option
For cancer patients, the medications they take are crucial to survive. A Wall Street Journal report looks into price-gouging, specifically on the brain cancer drug lomustine. Reporter Peter Loftus joins CBSN to talk about his article and the issues this creates for patients.